Characterisation of AD Animal Models: Building In Vivo Tools to Assess Next-Generation AD Therapeutics
ON-DEMAND By Charles River
This webinar highlights imaging as well as cognitive and physiological testing of AD models...
List view / Grid view
Webinars
Evaluating immunotherapeutic approaches with large scale functional assays for immuno-oncology
ON-DEMAND By IntelliCyt Corporation
In this webinar, Belen Ybarrondo, Ph.D and Thomas Duensing, Ph.D discuss the need for robust high content tools for current immunotherapeutic approaches, and how IntelliCyt's iQue Screener PLUS can give functional efficacy of immuno-oncology therapies...
High-throughput Screening: An Insider’s Guide to Outsourcing
ON-DEMAND By Charles River
This webinar reviews successful high throughput screening programs to provide an overview of the process from assay development to final data package...
Nuclear Imaging of CNS Diseases in Rodent Models
ON-DEMAND By Charles River
Charles River highlights new kinetic PET imaging and AIF as new tools in our comprehensive portfolio of imaging and associated ex vivo techniques...
Advancing the discovery of immunotherapeutics with large scale multiplexed experiments
ON-DEMAND By IntelliCyt Corporation
In this webinar, Belen Ybarrondo, Ph.D and Thomas Duensing, Ph.D discuss the challenges faced with antibody screening and how the iQue Screener can give an evaluation of cell killing mechanism, screening for immune checkpoint inhibitors and more...
Genomic support for target selection and validation in drug development: design of a new genotyping array
ON-DEMAND By Illumina
In this webinar, we focus on the use of microarray technology in drug development...
Key Ligand-Gated Ion Channels in CNS Drug Discovery
ON-DEMAND By Charles River
Ligand-gated ion channels including, GABAA, NMDA, and nicotinic acetylcholine receptors, are important therapeutic targets in neurological disorders...
Rapid identification and characterisation of Affimer technology
ON-DEMAND By Avacta Life Sciences
In this webinar we discuss Affimer® technology, a novel antibody mimetic and powerful antibody alternative...
Phenotypic Screening in Drug Discovery
ON-DEMAND By Charles River
This webinar describes an approach to phenotypic discovery through bioprofiling in human primary cell-based assays across several disease areas (case study)...
Identification of antibodies against difficult targets
ON-DEMAND By IntelliCyt
Identification of antibodies against challenging targets using high throughput multiplex-screening approaches...
Immunology Screening on the iQue Screener
ON-DEMAND By IntelliCyt
Immunology Screening on the iQue Screener: Assays for Immune-Modulators and Immunotherapy...
Webinar: Survey of Today’s Chemical Compound Libraries
ON-DEMAND By Charles River
This webinar discusses the gap between the compound profile of the industry’s current libraries and that of successful drugs approved in recent years...
Clinically relevant motor behaviors in Parkinson’s disease (PD) Models
ON-DEMAND By Charles River
The evolution of tools to analyze motor deficits in animal models and how Charles River is working to support the discovery of new Parkinson’s therapies...
Simultaneous detection of GPCR second messengers in living cells
ON-DEMAND By BMG Labtech GmbH
Due to their role in signal transmission from the outside to the inside of a cell, G-protein coupled receptors (GPCRs) are prominent drug targets.
The kinetics of drug binding
ON-DEMAND By BMG Labtech GmbH
Optimising the receptor binding kinetics of new drugs can have significant benefits, ranging from improved duration of action to enhanced efficacy through the insurmountable antagonism of dynamic physiological systems.Despite this, the kinetics of new receptor ligands are rarely measured early in the drug discovery process, largely because current assays are…
